Nissui competitive analysis

Latest publications and patents of Nissui New

Explore the latest publications and patents granted to Nissui, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Nissui

Oct 16, 2024Composition For Improving Vascular Endothelial FunctionGranted And Under Opposition
Aug 7, 2024Highly Unsaturated Fatty Acid Or Highly Unsaturated Fatty Acid Ethyl Ester With Reduced Environmental Pollutants, And Method For Producing SameGranted And Under Opposition
Mar 22, 2023Method Of Producing Oil/Fat Comprising Highly-Unsaturated Fatty Acids By Means Of LipasePatent Maintained As Amended
Nov 24, 2021Highly Unsaturated Fatty Acid Or Highly Unsaturated Fatty Acid Ethyl Ester With Reduced Environmental Pollutants, And Method For Producing SameGranted And Under Opposition

Explore Nissui's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 16, 2024Composition For Improving Vascular Endothelial Function1
Aug 7, 2024Highly Unsaturated Fatty Acid Or Highly Unsaturated Fatty Acid Ethyl Ester With Reduced Environmental Pollutants, And Method For Producing Same1
Mar 22, 2023Method Of Producing Oil/Fat Comprising Highly-Unsaturated Fatty Acids By Means Of Lipase1
Nov 24, 2021Highly Unsaturated Fatty Acid Or Highly Unsaturated Fatty Acid Ethyl Ester With Reduced Environmental Pollutants, And Method For Producing Same1

Latest PTAB cases involving Nissui

Discover the latest PTAB cases involving Nissui, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Nissui with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
NISSUI - 4 - - Non-Active
EPAX NORWAY31 - - Highly Aggressive
KD PHARMA BEXBACH2 - - - Highly Aggressive
PRONOVA BIOPHARMA NORGE1 - - 1Aggressive